BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25505248)

  • 1. Amitriptyline improves motor function via enhanced neurotrophin signaling and mitochondrial functions in the murine N171-82Q Huntington disease model.
    Cong WN; Chadwick W; Wang R; Daimon CM; Cai H; Amma J; Wood WH; Becker KG; Martin B; Maudsley S
    J Biol Chem; 2015 Jan; 290(5):2728-43. PubMed ID: 25505248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease.
    Jiang M; Peng Q; Liu X; Jin J; Hou Z; Zhang J; Mori S; Ross CA; Ye K; Duan W
    Hum Mol Genet; 2013 Jun; 22(12):2462-70. PubMed ID: 23446639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington's disease.
    Stepanova P; Kumar D; Cavonius K; Korpikoski J; Sirjala J; Lindholm D; Voutilainen MH
    Sci Rep; 2023 Feb; 13(1):2953. PubMed ID: 36807563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
    Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
    Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral vector mediated expression of mutant huntingtin in the dorsal raphe produces disease-related neuropathology but not depressive-like behaviors in wildtype mice.
    Pitzer M; Lueras J; Warden A; Weber S; McBride J
    Brain Res; 2015 May; 1608():177-90. PubMed ID: 25732261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease.
    Hathorn T; Snyder-Keller A; Messer A
    Neurobiol Dis; 2011 Jan; 41(1):43-50. PubMed ID: 20736066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease.
    Swarnkar S; Chen Y; Pryor WM; Shahani N; Page DT; Subramaniam S
    Neurobiol Dis; 2015 Oct; 82():66-77. PubMed ID: 26048156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease.
    Joshi AU; Ebert AE; Haileselassie B; Mochly-Rosen D
    J Mol Cell Cardiol; 2019 Feb; 127():125-133. PubMed ID: 30550751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of glatiramer acetate in Huntington's disease mouse models: Evidence for BDNF-elevating and immunomodulatory mechanisms.
    Corey-Bloom J; Aikin AM; Gutierrez AM; Nadhem JS; Howell TL; Thomas EA
    Brain Res; 2017 Oct; 1673():102-110. PubMed ID: 28823953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pridopidine rescues BDNF/TrkB trafficking dynamics and synapse homeostasis in a Huntington disease brain-on-a-chip model.
    Lenoir S; Lahaye RA; Vitet H; Scaramuzzino C; Virlogeux A; Capellano L; Genoux A; Gershoni-Emek N; Geva M; Hayden MR; Saudou F
    Neurobiol Dis; 2022 Oct; 173():105857. PubMed ID: 36075537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntington's Disease and Mitochondria.
    Jodeiri Farshbaf M; Ghaedi K
    Neurotox Res; 2017 Oct; 32(3):518-529. PubMed ID: 28639241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Olfactory Bulb BDNF Expression Does Not Rescue Deficits in Olfactory Neurogenesis in the Huntington's Disease R6/2 Mouse.
    Smail S; Bahga D; McDole B; Guthrie K
    Chem Senses; 2016 Mar; 41(3):221-32. PubMed ID: 26783111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease.
    Saydoff JA; Garcia RA; Browne SE; Liu L; Sheng J; Brenneman D; Hu Z; Cardin S; Gonzalez A; von Borstel RW; Gregorio J; Burr H; Beal MF
    Neurobiol Dis; 2006 Dec; 24(3):455-65. PubMed ID: 17011205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant heart rate and brainstem brain-derived neurotrophic factor (BDNF) signaling in a mouse model of Huntington's disease.
    Griffioen KJ; Wan R; Brown TR; Okun E; Camandola S; Mughal MR; Phillips TM; Mattson MP
    Neurobiol Aging; 2012 Jul; 33(7):1481.e1-5. PubMed ID: 22209255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime.
    Eckmann J; Clemens LE; Eckert SH; Hagl S; Yu-Taeger L; Bordet T; Pruss RM; Muller WE; Leuner K; Nguyen HP; Eckert GP
    Mol Neurobiol; 2014 Aug; 50(1):107-18. PubMed ID: 24633813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date.
    Squitieri F; de Yebenes JG
    Drug Des Devel Ther; 2015; 9():5827-33. PubMed ID: 26604684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model.
    Lu Z; Marks E; Chen J; Moline J; Barrows L; Raisbeck M; Volitakis I; Cherny RA; Chopra V; Bush AI; Hersch S; Fox JH
    Neurobiol Dis; 2014 Nov; 71():34-42. PubMed ID: 25014023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new drug design targeting the adenosinergic system for Huntington's disease.
    Huang NK; Lin JH; Lin JT; Lin CI; Liu EM; Lin CJ; Chen WP; Shen YC; Chen HM; Chen JB; Lai HL; Yang CW; Chiang MC; Wu YS; Chang C; Chen JF; Fang JM; Lin YL; Chern Y
    PLoS One; 2011; 6(6):e20934. PubMed ID: 21713039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model.
    Squitieri F; Di Pardo A; Favellato M; Amico E; Maglione V; Frati L
    J Cell Mol Med; 2015 Nov; 19(11):2540-8. PubMed ID: 26094900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-Associated Viral Vector Serotype DJ-Mediated Overexpression of N171-82Q-Mutant Huntingtin in the Striatum of Juvenile Mice Is a New Model for Huntington's Disease.
    Jang M; Lee SE; Cho IH
    Front Cell Neurosci; 2018; 12():157. PubMed ID: 29946240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.